Literature DB >> 33822246

Salivary C-reactive protein-a possible predictor of serum levels in pediatric acute respiratory illness.

Yoel Gofin1, Eliana Fanous2, Yehonatan Pasternak2,3, Zafnat Prokocimer2, Orna Zagoory-Sharon4, Ruth Feldman4, Gabriel Codick3,5, Orith Waisbourd-Zinman2,3, Sophia Fried2,3, Gilat Livni2,3.   

Abstract

Identifying the etiology of an acute respiratory infection in children is a well-known challenge. In this study, we evaluated the correlation between salivary C-reactive protein (CRP) and its serum counterpart, which is known to be higher in bacterial infections but necessitates a venipuncture. Salivary and serum CRPs were measured in children with an acute respiratory illness, aged 2 months to 18 years. Pearson's correlation coefficients were used to measure correlation. Discrimination of the salivary CRP levels for predicting serum levels above 100 mg/L was calculated and compared to serum CRP levels. Sensitivity and specificity were similarly calculated. Salivary CRP was measured in 104 samples. Levels correlated significantly and positively with serum CRP levels (r = 0.670, p<0.001). Area under the curve for predicting serum CRP levels of 100 mg/L was 0.848. For a salivary CRP concentration above 32,610 ng/L, the sensitivity and specificity were 69% and 93%, respectively, for accurately predicting a serum CRP level ≥100 mg/L.Conclusions: Salivary CRP can be used in the pediatric acute setting due to its high specificity for predicting elevated serum levels without the need for venipuncture. Further studies are required to achieve higher sensitivity rates. What is known: • Salivary C-reactive protein has shown correlation to its serum counterpart, mainly in healthy children, adults, and ill neonates. What is new: • In a large population of children with acute respiratory illness, aged 2 months to 18 years, salivary C-reactive protein showed high specificity for predicting elevated serum levels, thus indicating its potential as a diagnostic tool.

Entities:  

Keywords:  C-reactive protein; Children; Pneumonia; Saliva

Year:  2021        PMID: 33822246     DOI: 10.1007/s00431-021-04047-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  42 in total

Review 1.  Paediatric community-acquired pneumonia: current concept in pharmacological control.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Expert Opin Pharmacother       Date:  2003-05       Impact factor: 3.889

2.  Iatrogenic brachial and femoral artery complications following venipuncture in children.

Authors:  Omer Faruk Dogan; Metin Demircin; Ibrahim Ucar; Umit Duman; Mustafa Yilmaz; Erkmen Boke
Journal:  Heart Surg Forum       Date:  2006       Impact factor: 0.676

3.  British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.

Authors:  Michael Harris; Julia Clark; Nicky Coote; Penny Fletcher; Anthony Harnden; Michael McKean; Anne Thomson
Journal:  Thorax       Date:  2011-10       Impact factor: 9.139

4.  Effects of balloon inflation and cough trick methods on easing pain in children during the drawing of venous blood samples: a randomized controlled trial.

Authors:  Birsen Mutlu; Serap Balcı
Journal:  J Spec Pediatr Nurs       Date:  2015-03-28       Impact factor: 1.260

5.  The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children.

Authors:  Robert G Flood; Jennifer Badik; Stephen C Aronoff
Journal:  Pediatr Infect Dis J       Date:  2008-02       Impact factor: 2.129

6.  Conditioning and hyperalgesia in newborns exposed to repeated heel lances.

Authors:  Anna Taddio; Vibhuti Shah; Cheryl Gilbert-MacLeod; Joel Katz
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

7.  Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.

Authors:  Susanna Esposito; Sonia Bianchini; Monia Gambino; Barbara Madini; Giada Di Pietro; Giulia Umbrello; Maria Lory Presicce; Luca Ruggiero; Leonardo Terranova; Nicola Principi
Journal:  BMC Pulm Med       Date:  2016-07-20       Impact factor: 3.317

8.  Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.

Authors:  Mejbah U Bhuiyan; Christopher C Blyth; Rachel West; Jurissa Lang; Tasmina Rahman; Caitlyn Granland; Camilla de Gier; Meredith L Borland; Ruth B Thornton; Lea-Ann S Kirkham; Andrew Martin; Peter C Richmond; David W Smith; Adam Jaffe; Thomas L Snelling
Journal:  BMC Pulm Med       Date:  2019-04-02       Impact factor: 3.317

Review 9.  Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review.

Authors:  Jithin Thomas; Aiste Pociute; Rimantas Kevalas; Mantas Malinauskas; Lina Jankauskaite
Journal:  Ital J Pediatr       Date:  2020-01-09       Impact factor: 2.638

Review 10.  Global burden of childhood pneumonia and diarrhoea.

Authors:  Christa L Fischer Walker; Igor Rudan; Li Liu; Harish Nair; Evropi Theodoratou; Zulfiqar A Bhutta; Katherine L O'Brien; Harry Campbell; Robert E Black
Journal:  Lancet       Date:  2013-04-12       Impact factor: 79.321

View more
  1 in total

1.  Salivary C-Reactive Protein and Mean Platelet Volume in the Diagnosis and Follow-Up of Community-Acquired Pneumonia in Infants.

Authors:  Ahmed Omran; Hala Abohadid; Mai H S Mohammad; Sherien Shalaby
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-12-02       Impact factor: 1.349

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.